DexMat
PrivateLast Round
Seed Round
Aug 19, 2026
Total Funding Raised
$10.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DexMat is a materials science company that manufactures Galvorn, a high-performance carbon nanotube material intended to serve as a lightweight, strong, and flexible alternative to metals like copper, steel, and aluminum.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Sustainable Materials, Defense Tech, Energy Storage
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DexMat Comparables
Compare DexMat with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CHASM Advanced Materials | 80% | |
| Hamamatsu Carbonics Co., Ltd. | 78% | |
| LINTEC CORP. | 77% | |
DexMat Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 19, 2026 | ||||
| Seed | Jan 28, 2026 | ||||
| Grant | Feb 6, 2024 | ||||
| Grant | Sep 14, 2023 | ||||
| Seed | Mar 8, 2023 | ||||
Grant | May 20, 2022 |
DexMat Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tailwind Futures | Seed |
| Air Force Research Laboratory | Grant |
| Climate Avengers | Seed |
| Capital Factory | Seed |
| Collaborative Fund | Seed |
| Shell Ventures | Seed |
| Aramco Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
Raised $1M in Seed funding.
- Jan 28, 2026
$5M round led by non sibi ventures
DexMat Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DexMat's valuation, stock price, and market status.